Key Record Dates
ClinicalTrials.gov Identifier: | NCT02704156 |
---|---|
Brief Title: | SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer |
First Submitted : | March 1, 2016 |
First Submitted that Met QC Criteria : | March 8, 2016 |
First Posted : | March 9, 2016 (Estimate) |
Results First Submitted : | January 6, 2021 |
Results First Submitted that Met QC Criteria : | January 29, 2021 |
Results First Posted : | February 16, 2021 |
Last Update Submitted that Met QC Criteria : | February 28, 2022 |
Last Update Posted : | May 13, 2022 |